Start with a low, welldocumented dose and maintain consistent use for at least eight weeks before judging
Several warnings came only after many patients were already harmed: the FDA added an ileus warning in September 2023, and a new warning for severe gastrointestinal reactions in January 2025
Patients with conditions characterized by chronic inflammation, such as cardiovascular disease, metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD), or metabolic syndrome, should discuss how tirzepatide fits into their comprehensive management plan
PlexusDx provides optional Precision Peptide Genetic Testing to support clinical conversations about individual peptide-pathway predispositions, interpreted with your provider
For some patients, weight loss improves body confidence and hormonal function enough to increase libido
They are not a fly-by-night operation that disappears after a few months, but they also lack the established track record of vendors who have been serving the research community for a decade or more